CN1015622B - 氢化肉桂酸衍生物和其制法 - Google Patents
氢化肉桂酸衍生物和其制法Info
- Publication number
- CN1015622B CN1015622B CN88104521A CN88104521A CN1015622B CN 1015622 B CN1015622 B CN 1015622B CN 88104521 A CN88104521 A CN 88104521A CN 88104521 A CN88104521 A CN 88104521A CN 1015622 B CN1015622 B CN 1015622B
- Authority
- CN
- China
- Prior art keywords
- formula
- hydrogen
- compound
- chloro
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/31—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH276487 | 1987-07-21 | ||
| CH2764/87 | 1987-07-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1036952A CN1036952A (zh) | 1989-11-08 |
| CN1015622B true CN1015622B (zh) | 1992-02-26 |
Family
ID=4241087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN88104521A Expired CN1015622B (zh) | 1987-07-21 | 1988-07-20 | 氢化肉桂酸衍生物和其制法 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US4883815A (enExample) |
| EP (1) | EP0300371A1 (enExample) |
| JP (1) | JPS6447748A (enExample) |
| KR (1) | KR890001954A (enExample) |
| CN (1) | CN1015622B (enExample) |
| AU (1) | AU603470B2 (enExample) |
| DD (1) | DD277071A5 (enExample) |
| DK (1) | DK405888A (enExample) |
| FI (1) | FI883441A7 (enExample) |
| GB (1) | GB2207135B (enExample) |
| HU (1) | HU198676B (enExample) |
| IL (1) | IL87130A0 (enExample) |
| IN (1) | IN167395B (enExample) |
| IS (1) | IS3376A7 (enExample) |
| MC (1) | MC1960A1 (enExample) |
| MT (1) | MTP1023B (enExample) |
| MW (1) | MW2688A1 (enExample) |
| NO (1) | NO883233L (enExample) |
| NZ (1) | NZ225442A (enExample) |
| OA (1) | OA08746A (enExample) |
| PT (1) | PT88041A (enExample) |
| TN (1) | TNSN88076A1 (enExample) |
| YU (2) | YU141488A (enExample) |
| ZA (1) | ZA885102B (enExample) |
| ZW (1) | ZW9288A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
| US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
| ES2125884T3 (es) * | 1991-08-21 | 1999-03-16 | Lilly Co Eli | Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa. |
| WO1993023360A1 (en) * | 1992-05-12 | 1993-11-25 | Zeria Pharmaceutical Co., Ltd. | Novel quaternary ammonium salts and use thereof as medicine |
| US6172235B1 (en) | 1996-08-09 | 2001-01-09 | Merck & Co., Inc. | Asymmetric conjugate addition reaction |
| WO1998006698A1 (en) * | 1996-08-09 | 1998-02-19 | Merck & Co., Inc. | An asymmetric conjugate addition reaction |
| US5849914A (en) * | 1996-08-09 | 1998-12-15 | Merck & Co., Inc. | Compounds formed by an asymmetric conjugate addition reaction |
| GB9920872D0 (en) * | 1999-09-04 | 1999-11-10 | Glaxo Group Ltd | Benzophenones as inhibitors of reverse transcriptase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3795683A (en) * | 1970-08-19 | 1974-03-05 | Hoffmann La Roche | 2,3,4,5-tetrahydro-1h-3-benzazepines |
| JPS6033439B2 (ja) * | 1980-03-07 | 1985-08-02 | 財団法人相模中央化学研究所 | ジペプチドの製造方法 |
| IT1175926B (it) * | 1984-01-13 | 1987-08-12 | Debi Derivati Biologici | Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina |
| DE3773950D1 (de) * | 1986-01-23 | 1991-11-28 | Hoffmann La Roche | Benzazecin-derivate. |
-
1988
- 1988-06-22 IN IN425/MAS/88A patent/IN167395B/en unknown
- 1988-07-05 MW MW26/88A patent/MW2688A1/xx unknown
- 1988-07-05 US US07/215,003 patent/US4883815A/en not_active Expired - Fee Related
- 1988-07-06 MT MT1023A patent/MTP1023B/xx unknown
- 1988-07-06 ZW ZW92/88A patent/ZW9288A1/xx unknown
- 1988-07-14 EP EP88111347A patent/EP0300371A1/de not_active Withdrawn
- 1988-07-14 ZA ZA885102A patent/ZA885102B/xx unknown
- 1988-07-15 IL IL87130A patent/IL87130A0/xx unknown
- 1988-07-18 MC MC881992A patent/MC1960A1/fr unknown
- 1988-07-18 HU HU883759A patent/HU198676B/hu not_active IP Right Cessation
- 1988-07-18 TN TNTNSN88076A patent/TNSN88076A1/fr unknown
- 1988-07-18 NZ NZ225442A patent/NZ225442A/en unknown
- 1988-07-18 AU AU19176/88A patent/AU603470B2/en not_active Ceased
- 1988-07-19 KR KR1019880008982A patent/KR890001954A/ko not_active Withdrawn
- 1988-07-19 DD DD88318084A patent/DD277071A5/de not_active IP Right Cessation
- 1988-07-20 FI FI883441A patent/FI883441A7/fi not_active IP Right Cessation
- 1988-07-20 JP JP63179300A patent/JPS6447748A/ja active Pending
- 1988-07-20 CN CN88104521A patent/CN1015622B/zh not_active Expired
- 1988-07-20 NO NO88883233A patent/NO883233L/no unknown
- 1988-07-20 IS IS3376A patent/IS3376A7/is unknown
- 1988-07-20 DK DK405888A patent/DK405888A/da not_active Application Discontinuation
- 1988-07-20 PT PT88041A patent/PT88041A/pt not_active Application Discontinuation
- 1988-07-20 GB GB8817291A patent/GB2207135B/en not_active Expired - Lifetime
- 1988-07-21 OA OA59392A patent/OA08746A/xx unknown
- 1988-07-21 YU YU01414/88A patent/YU141488A/xx unknown
-
1989
- 1989-09-06 US US07/403,532 patent/US5017608A/en not_active Expired - Fee Related
-
1990
- 1990-03-01 YU YU00398/90A patent/YU39890A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK405888A (da) | 1989-01-22 |
| DD277071A5 (de) | 1990-03-21 |
| EP0300371A1 (de) | 1989-01-25 |
| AU603470B2 (en) | 1990-11-15 |
| NO883233D0 (no) | 1988-07-20 |
| HU198676B (en) | 1989-11-28 |
| MTP1023B (en) | 1989-07-18 |
| PT88041A (pt) | 1989-06-30 |
| YU141488A (en) | 1990-06-30 |
| US4883815A (en) | 1989-11-28 |
| US5017608A (en) | 1991-05-21 |
| IN167395B (enExample) | 1990-10-20 |
| IL87130A0 (en) | 1988-12-30 |
| OA08746A (fr) | 1989-03-31 |
| NZ225442A (en) | 1991-05-28 |
| FI883441A7 (fi) | 1989-01-22 |
| TNSN88076A1 (fr) | 1990-07-10 |
| KR890001954A (ko) | 1989-04-06 |
| GB8817291D0 (en) | 1988-08-24 |
| YU39890A (en) | 1991-10-31 |
| CN1036952A (zh) | 1989-11-08 |
| IS3376A7 (is) | 1989-01-22 |
| JPS6447748A (en) | 1989-02-22 |
| DK405888D0 (da) | 1988-07-20 |
| NO883233L (no) | 1989-01-23 |
| MC1960A1 (fr) | 1989-06-30 |
| AU1917688A (en) | 1989-01-27 |
| FI883441A0 (fi) | 1988-07-20 |
| ZW9288A1 (en) | 1989-02-01 |
| GB2207135A (en) | 1989-01-25 |
| GB2207135B (en) | 1991-05-15 |
| ZA885102B (en) | 1989-03-29 |
| HUT47077A (en) | 1989-01-30 |
| MW2688A1 (en) | 1989-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1034552C (zh) | 十氢异喹啉衍生物的药物制剂的制备方法 | |
| CN1028104C (zh) | 制备喹诺酮衍生物的方法 | |
| CN1083431C (zh) | 新的杂环化合物 | |
| CN86107627A (zh) | 新颖的4-苄基-1-(2h)-酞嗪酮衍生物的制备方法 | |
| CN1406225A (zh) | 用作nk-3和nk-2受体拮抗剂的喹啉-4-甲酰胺衍生物 | |
| HK1041887A1 (en) | Fused pyrazolyl compounds, a composition comprising the same, and the use of the same | |
| CN1036064C (zh) | 新的具有ngf生成促进活性的苯衍生物的制备方法 | |
| CN1114651A (zh) | 3-吲哚基哌啶 | |
| CN1227544A (zh) | 作为兴奋性氨基酸拮抗剂的四氢喹啉衍生物 | |
| CN1264378A (zh) | 作为nk-2和nk-3受体拮抗剂的喹啉-4-甲酰胺衍生物 | |
| CN1500085A (zh) | 降低脂质的联苯基甲酰胺 | |
| CN1015622B (zh) | 氢化肉桂酸衍生物和其制法 | |
| CN1756740A (zh) | 具有2,6-二取代苯乙烯基的含氮杂环衍生物 | |
| CN86107695A (zh) | 不同的氮-取代的3-哌啶羧酸或氮-取代的3-吡啶羧酸及它们的衍生物 | |
| CN1067985C (zh) | 吲哚衍生物及含它们的药物 | |
| CN1097006A (zh) | O-芳基吗啡喃的醚类化合物 | |
| CN1069491A (zh) | 2-(哌啶-1-基)乙醇衍生物,其制法及其治疗应用 | |
| CN1890217A (zh) | 作为载脂蛋白b抑制剂的n-芳基哌啶取代的联苯基甲酰胺 | |
| CN87100312A (zh) | 苯并氮杂环癸五烯衍生物 | |
| CN1167682C (zh) | 毒蕈碱拮抗剂 | |
| CN87100686A (zh) | 用作心血管剂的3-烷氧基-2-氨基丙胺类化合物 | |
| CN1705648A (zh) | 具有ACAT抑制活性的а-苯基N-乙酰苯胺衍生物及其治疗应用 | |
| CN1742004A (zh) | 具有止痛活性的吲唑酰胺类 | |
| CN1135216A (zh) | 光学活性咪唑烷酮衍生物及其制造方法 | |
| CN1926122A (zh) | 二芳基甲基哌嗪衍生物及其制备并用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C13 | Decision | ||
| GR02 | Examined patent application | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |